Interphex Insider: The Future-Ready Biomanufacturing Facility
Meg Carr reflects on the key themes from this year’s show – from contamination control and AI to flexible facility design
False
Meg Carr reflects on the key themes from this year’s show – from contamination control and AI to flexible facility design
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 5, 2026
4 min read
Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines
October 1, 2026
3 min read
Cellares Co-Founder and CEO discusses why the future of cell therapy depends on rethinking how therapies are made
September 28, 2026
2 min read
Renee Aguiar-Lucander argues that faster clinical trials and more pragmatic regulation are essential to bringing medicines to patients sooner
September 22, 2026
5 min read
CCRM CEO Michael May on quantum computing, commercialization, and the next era of cell therapy
False
Affiliations:
Specialties:
Areas of Expertise: